Results 101 to 110 of about 1,848 (184)

Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials. [PDF]

Cureus
Messori A, Brunoro R, Paolì MG, Rivano M.   +3 more
europepmc   +1 more source

Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review. [PDF]

Adv Ther
Elwing JM, Krishnan M, Parikh KS, Sargent T, Wu S, Benninger C, Doad G, Hill W, Oswald C, Bridge DC, O'Donovan P, Maranes LV, Miller C.   +12 more
europepmc   +1 more source

Could We Maintain the Initial Efficacy of Triple Sequential Combination Therapies with Selexipag Against Progressive Deterioration Risk in Patients with Pulmonary Arterial Hypertension: Insights from a Single-Center Study? [PDF]

Anatol J Cardiol
Tokgöz HC, Kaymaz C, Kültürsay B, Tanyeri S, Buluş Ç, Sırma D, Atıcı ŞZ, Kibar M, Küçük A, Çiçek ŞN, Vezir A, Erdem C, Erdoğan FB, Doğan F, Hakgör A, Keskin B, Bayram Z, Sekban A, Karagöz A, Tanboga İH, Özdemir N.   +20 more
europepmc   +1 more source

Towards an integrated and proactive management of pulmonary hypertension in systemic sclerosis: a practical approach for early diagnosis and optimal patient management. [PDF]

Rheumatol Adv Pract
Giuggioli D, Del Galdo F, D'Alto M, Matucci-Cerinic M.   +3 more
europepmc   +1 more source

Selexipag for Pulmonary Hypertension, TAVI and more. [PDF]

Anatol J Cardiol
Erol Ç.
europepmc   +1 more source

Delayed-onset portopulmonary hypertension following liver transplantation with near hemodynamic normalization on triple therapy. [PDF]

Respir Med Case Rep
Abdullah M, Roche S, Mwangi J, Arnold L.
europepmc   +1 more source

Rodatristat ethyl decreases activity in pulmonary arterial hypertension: results from the ELEVATE-2 trial. [PDF]

Ann Am Thorac Soc
Lachant DJ, Sahay S, Block R, Ossip D, Denning J, Lazarus HM, Parsley E, White RJ.   +7 more
europepmc   +1 more source

Activin signaling inhibitor Sotatercept in pulmonary veno-occlusive disease: building a bridge to transplantation? [PDF]

Respir Med Case Rep
Mietzner M, Held M, Pfeuffer-Jovic E.
europepmc   +1 more source

Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study. [PDF]

BMJ Open Respir Res
Scelsi L, Badagliacca R, Vicenzi M, Di Poi E, Baldi F, Ameri P, Airò E, Bux F, Lorenzo D, Giuliani L, Perna GP, Bonsante E, D'Agostino C, Raineri C, Agostoni P, Cappuccio A, Greco E, Marini MG, Biancospino M, Uglietti A, De Santis S.   +20 more
europepmc   +1 more source

Multimodal Management of Chronic Thromboembolic Pulmonary Hypertension: A Narrative Review of Treatment Selection and Sequencing. [PDF]

J Cardiovasc Dev Dis
Gharsalli H, Alshahrani M, Harbi O, Alwadai N, Al-Asiri AM, Alahmari F, Alqahtani A, Al-Jahash N, Abbag L, Alqahtani S, Amer KA.   +10 more
europepmc   +1 more source